Join the DDA or

Use ampoules in anaphylaxis kits while auto-injector shortage persists

NHS Improvement issues advice for dispensers

October 12th 2018

Tagged: Clinical guidance news Dispensary guidance news

By Ailsa Colquhoun

New advice from NHS Improvement asks GPs and dispensers to restock anaphylaxis kits with ampoules rather than adrenaline auto injectors (AAIs), in order to preserve AAI stocks.

GP teams are asked to ensure that as well as ampoules, the kits also include dosing charts, needles and syringes.

The Green Book and Resus Council guidance provide additional advice to healthcare professionals on the use of adrenaline in response to anaphylaxis.

Dentists and schools have also received communications about the AAI shortage situation.

Further information for GPs and dispensers, including on the availability of adrenaline ampoules, is included in the latest Department of Health and Social Care medicines supply team update, along with updates on the supply of the following items:

  • Sinemet (co-careldopa) tablets
  • Ativan (lorazepam) injection
  • Zemplar (paricalcitol) 2mcg capsules
  • Tambocor (flecainide) 200mg modified release tablets
  • Clomipramine
  • Promazine tablets
  • Adalat (Nifedipine) all products
  • Imigran (sumatriptan) injection
  • Diazepam 5mg/ml Emulsion for injection (Diazemuls)
  • Colestyramine (Questran)
  • Lofexidine tablets
  • Menadiol tablets
  • Acetazolamide MR
  • Trimovate cream
  • Trifluoperazine tablets
  • Zaditen (ketotifen) 300ml (1.38mg in 5 ml oral solution)
  • Allergan Lacri-Lube
  • Bausch & Lomb: Lotemax; Atropine Minims
  • Novartis Iopodine ED Solution 5mg/ml 5ml (1×1)  
  • RPH Pharmaceuticals AB: Betnesol Eye Ointment 0.1% w/w x 3g

For all the latest news of the 2018 DDA annual conference...

Learn more